Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 7/20 | 0.65 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.65 |
| ▸ | NTSR1 | P30989 | 4/20 | 0.51 |
| ▸ | NTSR2 | O95665 | 3/20 | 0.51 |
| ▸ | SORT1 | Q99523 | 3/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | F2 | P00734 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30287598 | 0.97 | OPRD1 (0.62) | OPRD1OPRM1NTSR1NTSR2SORT1 | |
| SCHEMBL30116350 | 0.96 | OPRD1 (0.59) | OPRD1OPRM1NTSR1NTSR2SORT1 | |
| SCHEMBL30631183 | 0.96 | OPRD1 (0.60) | OPRD1OPRM1NTSR1NTSR2SORT1 | |
| SCHEMBL30116346 | 0.95 | OPRD1 (0.59) | OPRD1OPRM1 | |
| SCHEMBL30116343 | 0.95 | OPRD1 (0.59) | OPRD1OPRM1 | |
| SCHEMBL30533414 | 0.95 | OPRD1 (0.59) | OPRD1OPRM1NTSR1NTSR2SORT1 | |
| SCHEMBL29765222 | 0.95 | OPRM1 (0.62) | OPRD1OPRM1NTSR1NTSR2SORT1 | |
| SCHEMBL30629451 | 0.95 | OPRD1 (0.59) | OPRD1OPRM1NTSR1NTSR2SORT1 | |
| SCHEMBL30116347 | 0.93 | OPRD1 (0.57) | OPRD1OPRM1NTSR1NTSR2SORT1 | |
| SCHEMBL30503059 | 0.93 | OPRD1 (0.56) | OPRD1OPRM1NTSR1NTSR2SORT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116209475-A | Therapeutic uses comprising a triple agonist long-acting conjugate or a combination of triple agonists | 韩美药品株式会社 | 2023-06-02 | — | — | CN | disclosed |
| CN-115697375-A | Pharmaceutical composition comprising GLP-2 derivatives or long-acting conjugates thereof for the prevention or treatment of mucositis induced by radiotherapy, chemotherapy or a combination thereof | 韩美药品株式会社 | 2023-02-03 | — | — | CN | disclosed |